Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 111 peer-reviewed journal articles Updated
Oncology

Non-Hodgkin Lymphoma Resource Guide

At a Glance

Non-Hodgkin lymphoma (NHL) treatment and prognosis depend heavily on whether the disease is slow-growing (indolent) or fast-growing (aggressive). This guide helps patients navigate their diagnosis, decode pathology reports, understand Ann Arbor staging, and explore therapies like R-CHOP and CAR-T.

Finding out you have Non-Hodgkin Lymphoma (NHL) often brings a wave of intense emotions. It is common to feel overwhelmed, anxious, or even numb after receiving the news [1]. Research shows that patients are particularly vulnerable to high levels of clinical anxiety and depression during this initial phase [2][3].

This guide is designed to empower you with the knowledge you need to navigate your diagnosis, understand your treatment options, and effectively partner with your medical team. We have structured this resource to walk you through every phase of the NHL journey.

Navigating This Guide

To help you find the information you need, we have divided this resource into specific topics:

01

Recognizing the Signs: Symptoms of Non-Hodgkin Lymphoma

Learn the early signs and symptoms of Non-Hodgkin Lymphoma (NHL). Understand B symptoms, swollen lymph nodes, and when to discuss them with your doctor.

02

Comparing Subtypes: How Indolent and Aggressive Lymphomas Differ

Learn the differences between indolent (slow-growing) and aggressive (fast-growing) Non-Hodgkin Lymphoma. Understand DLBCL, Follicular, and transformation.

03

Cracking the Code: Understanding Your Pathology Report

Learn how to read your Non-Hodgkin lymphoma pathology report. Understand markers like CD20, the Ki-67 index, double-hit status, and your biopsy results.

04

Mapping the Disease: Staging and Your Prognosis

Learn how Non-Hodgkin lymphoma (NHL) is staged using the Ann Arbor system. Understand what stages I-IV mean, B symptoms, PET scans, and IPI prognostic scores.

05

Treatment Pathways: Navigating Your Options

Explore Non-Hodgkin lymphoma (NHL) treatment options. Learn about watch and wait, standard R-CHOP chemotherapy, CAR T-cell therapy, and stem cell transplants.

06

Building Your Care Team and Preparing for Your First Visit

Learn how to build a multidisciplinary care team for Non-Hodgkin lymphoma. Find out what medical records to bring to your first oncology visit.

07

Life After Treatment: Navigating Survivorship and Long-Term Health

Learn about Non-Hodgkin Lymphoma (NHL) survivorship. Understand your long-term surveillance schedule, how to manage scanxiety, and potential late effects.

You do not need to read everything at once. We recommend starting with your pathology report and understanding your specific subtype, as this will guide the rest of your journey. Remember, you are a vital member of your own care team, and being informed is your best advocacy tool.

Common questions in this guide

What are the main types of Non-Hodgkin lymphoma?
Non-Hodgkin lymphomas are generally categorized into two main groups: slow-growing (indolent) and fast-growing (aggressive). Knowing your specific subtype is the most crucial step in determining your treatment plan and prognosis.
Why is understanding my lymphoma pathology report important?
Your pathology report contains the detailed results of your biopsy. It identifies your specific NHL subtype and includes critical medical terms that confirm your diagnosis, which directly guides your treatment options.
How is Non-Hodgkin lymphoma staged?
Doctors use the Ann Arbor staging system to map the extent of the disease and calculate your risk using an IPI score. It is important to know that a Stage IV diagnosis in lymphoma is treated differently and has a different outlook than Stage IV in solid tumors.
What are the treatment options for Non-Hodgkin lymphoma?
Treatment pathways depend on your specific diagnosis. Common options include standard therapies like R-CHOP, as well as advanced treatments like CAR-T cell therapy for certain patients.
Should my family or caregivers read this lymphoma guide with me?
Yes, it is highly recommended to have your support system review your resources with you. They can help you process complex medical information, take notes, and ask your care team important questions during appointments.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific diagnosis, which sections of this resource guide are most critical for me to review first?
  2. 2.How will my care team help me navigate the transition between the different phases of my treatment journey outlined here?
  3. 3.Are there any specific lifestyle modifications you recommend I start making today?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (3)
  1. 1

    Anxiety prevalence in lymphoma: A systematic review and meta-analysis.

    Vargas-Román K, Díaz-Rodríguez CL, Cañadas-De la Fuente GA, et al.

    Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2020; (39(7)):580-588 doi:10.1037/hea0000869.

    PMID: 32212767
  2. 2

    Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin's lymphoma: a cohort study of the French national health insurance database.

    Conte C, Rueter M, Laurent G, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016; (24(11)):4791-9 doi:10.1007/s00520-016-3331-y.

    PMID: 27435321
  3. 3

    Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany.

    Tilch MK, Galle PR, Schattenberg JM, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022; (30(3)):2387-2395 doi:10.1007/s00520-021-06677-w.

    PMID: 34761297

This guide is for educational purposes only and does not replace professional medical advice. Always consult your hematologist or oncologist regarding your specific Non-Hodgkin lymphoma diagnosis and treatment plan.

Get notified when new evidence is published on Non-Hodgkin lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.